Patents by Inventor Magali VERCAUTEREN

Magali VERCAUTEREN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase
    Patent number: 10189839
    Abstract: The present invention relates to compounds of the formula (I) wherein R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.
    Type: Grant
    Filed: November 18, 2014
    Date of Patent: January 29, 2019
    Assignee: ACTELION PHARMACEUTICALS LTD
    Inventors: Daniel Bur, Corinna Grisostomi, Oliver Nayler, Lubos Remen, Magali Vercauteren, Richard Welford
  • TRICYCLIC PIPERIDINE COMPOUNDS
    Publication number: 20180155344
    Abstract: The present invention relates to compounds of the formula (I) wherein R1a, R1b, R2, R3, (R4)n and ring (A) are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.
    Type: Application
    Filed: May 3, 2016
    Publication date: June 7, 2018
    Applicant: ACTELION PHARMACEUTICALS LTD
    Inventors: Daniel BUR, Corinna GRISOSTOMI, Thierry KIMMERLIN, Lubos REMEN, Hervé SIENDT, Magali VERCAUTEREN, Richard WELFORD
  • Tricyclic piperidine compounds
    Patent number: 9765092
    Abstract: The present invention relates to compounds of the formula (I) wherein R, R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.
    Type: Grant
    Filed: November 18, 2014
    Date of Patent: September 19, 2017
    Assignee: ACTELION PHARMACEUTICALS LTD
    Inventors: Daniel Bur, Corinna Grisostomi, Oliver Nayler, Lubos Remen, Magali Vercauteren, Richard Welford
  • TRICYCLIC IMIDAZOLE COMPOUNDS AS INHIBITORS OF TRYPTOPHAN HYDROXYLASE
    Publication number: 20160289232
    Abstract: The present invention relates to compounds of the formula (I) wherein R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.
    Type: Application
    Filed: November 18, 2014
    Publication date: October 6, 2016
    Inventors: Daniel BUR, Corinna GRISOSTOMI, Oliver NAYLER, Lubos REMEN, Magali VERCAUTEREN, Richard WELFORD
  • TRICYCLIC PIPERIDINE COMPOUNDS
    Publication number: 20160272655
    Abstract: The present invention relates to compounds of the formula (I) wherein R, R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.
    Type: Application
    Filed: November 18, 2014
    Publication date: September 22, 2016
    Inventors: Daniel BUR, Corinna GRISOSTOMI, Oliver NAYLER, Lubos REMEN, Magali VERCAUTEREN, Richard WELFORD